Co-structure of the Fab of the anti-TIGIT Vibostolimab antibody with its antigen
External Resource: Annotation
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Heavy Chain | IGHV6 | - | t-cell immunoreceptor with ig and itim domains | SAbDab (2025-12-19) |
| | Light Chain | IGKV4 | Kappa | t-cell immunoreceptor with ig and itim domains | SAbDab (2025-12-19) |
| Chain | Name | Target | Provenance Source |
|---|
| Tiragolumab | TIGIT/WUCAM/VSTM3 | Therapeutic SAbDab (2025-12-19) |
| Tiragolumab | TIGIT/WUCAM/VSTM3 | Therapeutic SAbDab (2025-12-19) |
| Chains | Polymer | Molecular Function | Biological Process | Cellular Component |
|---|
| T-cell immunoreceptor with Ig and ITIM domains | | | |
| Tiragolumab antibody heavy chain variable domains | - | - | - |
| Tiragolumab antibody light chain variable domains | - | - | - |
| Chains | Drug Target   | Associated Disease |
|---|
| Pharos:  Q495A1 | |